Differentiation of rebound and lymphoid Thymic hyperplasia from anterior mediastinal tumors with dual-echo chemical-shift MR imaging in adulthood: Reliability of the chemical-shift ratio and signal intensity index

Radiology

Volumn 274, Issue 1, 2015, Pages 238-249

  Priola, Adriano M ^a   Priola, Sandro M ^a   Ciccone, Giovannino ^b   Evangelista, Andrea ^b   Cataldi, Aldo ^a   Gned, Dario ^a   Pazè, Francesco ^a   Ducco, Lorena ^a   Moretti, Federica ^a   Brundu, Maria ^a   Veltri, Andrea ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHEMICAL SHIFT RATIO; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DUAL ECHO CHEMICAL SHIFT MAGNETIC RESONANCE IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; LIMIT OF DETECTION; LYMPHOID THYMUS HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM TUMOR; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOLOGICAL PARAMETERS; REBOUND THYMUS HYPERPLASIA; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SIGNAL INTENSITY INDEX; THYMUS HYPERPLASIA; TUMOR DIFFERENTIATION; ADOLESCENT; COMPUTER ASSISTED TOMOGRAPHY; LYMPH NODE; LYMPHOMA; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; THYMOMA; THYMUS NEOPLASMS; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPH NODES; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; THYMOMA; THYMUS HYPERPLASIA; THYMUS NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84919779383     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14132665     Document Type: Article

References (29)

1. Hood MN, Ho VB, Smirniotopoulos JG, Szumowski J. Chemical shift: the artifact and clinical tool revisited. RadioGraphics 1999; 19(2): 357-371.
2. Haider MA, Ghai S, Jhaveri K, Lockwood G. Chemical shift MR imaging of hyperattenuating (.10 HU) adrenal masses: does it still have a role? Radiology 2004; 231(3): 711-716.
3. Fujiyoshi F, Nakajo M, Fukukura Y, Tsuchimochi S. Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR Am J Roentgenol 2003; 180(6): 1649-1657.
4. Tsushima Y, Ishizaka H, Matsumoto M. Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging. Radiology 1993; 186(3): 705-709.
5. Takahashi K, Inaoka T, Murakami N, et al. Characterization of the normal and hyperplas-tic thymus on chemical-shift MR imaging. AJR Am J Roentgenol 2003; 180(5): 1265-1269.
6. Inaoka T, Takahashi K, Mineta M, et al. Thymic hyperplasia and thymus gland tumors: differentiation with chemical shift MR imaging. Radiology 2007; 243(3): 869-876.
7. Takahashi K, Al-Janabi NJ. Computed tomography and magnetic resonance imaging of mediastinal tumors. J Magn Reson Imaging 2010; 32(6): 1325-1339.
8. Priola AM, Priola SM. Imaging of thymus in myasthenia gravis: from thymic hyperplasia to thymic tumor. Clin Radiol 2014; 69(5): e230-e245.
9. Ackman JB, Mino-Kenudson M, Morse CR. Nonsuppressing normal thymus on chemical shift magnetic resonance imaging in a young woman. J Thorac Imaging 2012; 27(6): W196-W198.
10. Park BK, Kim CK, Kim B, Lee JH. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 2007; 243(3): 760-765.
11. Inaoka T, Takahashi K, Iwata K, et al. Evaluation of normal fatty replacement of the thymus with chemical-shift MR imaging for identification of the normal thymus. J Magn Reson Imaging 2005; 22(3): 341-346.
12. Popa GA, Preda EM, Scheau C, Vilciu C, Lupescu IG. Updates in MRI characterization of the thymus in myasthenic patients. J Med Life 2012; 5(2): 206-210.
13. Ackman JB, Kovacina B, Carter BW, et al. Sex difference in normal thymic appearance in adults 20-30 years of age. Radiology 2013; 268(1): 245-253.
14. Priola SM, Priola AM, Cardinale L, Perotto F, Fava C. The anterior mediastinum: anatomy and imaging procedures. Radiol Med (Torino) 2006; 111(3): 295-311.
15. Nasseri F, Eftekhari F. Clinical and radio-logic review of the normal and abnormal thymus: pearls and pitfalls. RadioGraphics 2010; 30(2): 413-428.
16. Cassidy FH, Yokoo T, Aganovic L, et al. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. RadioGraphics 2009; 29(1): 231-260.
17. Israel GM, Korobkin M, Wang C, Hecht EN, Krinsky GA. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR Am J Roentgenol 2004; 183(1): 215-219.
18. Boyd E. The weight of the thymus gland in health and in disease. Am J Dis Child 1932; 43(5 Pt 1): 1162-1214.
19. Wernecke K, Vassallo P, Rutsch F, Peters PE, Potter R. Thymic involvement in Hodgkin disease: CT and sonographic findings. Radiology 1991; 181(2): 375-383.
20. Priola AM, Priola SM, Cardinale L, Cataldi A, Fava C. The anterior mediastinum: diseases. Radiol Med (Torino) 2006; 111(3): 312-342.
21. Spiers AS, Husband JE, MacVicar AD. Treated thymic lymphoma: comparison of MR imaging with CT. Radiology 1997; 203(2): 369-376.
22. Rahmouni A, Divine M, Lepage E, et al. Mediastinal lymphoma: quantitative changes in gadolinium enhancement at MR imaging after treatment. Radiology 2001; 219(3): 621-628.
23. Priola AM, Priola SM. Primary mediastinal Hodgkin lymphoma and rebound thymic hyperplasia: differentiation with chemical-shift magnetic resonance imaging after treatment. Int J Hematol 2009; 90(1): 8-10.
24. Gawande RS, Khurana A, Messing S, et al. Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT. Radiology 2012; 262(2): 613-622.
25. Jerushalmi J, Frenkel A, Bar-Shalom R, Khoury J, Israel O. Physiologic thymic uptake of 18F-FDG in children and young adults: a PET/CT evaluation of incidence, patterns, and relationship to treatment. J Nucl Med 2009; 50(6): 849-853.
26. Priola AM, Veltri A, Priola SM. FDG PET/CT for the evaluation of normal thymus, lymphoma recurrence, and mediastinal lymphoma in pediatric patients. Radiology 2012; 264(3): 918-919; author reply 919-920.
27. Patel PM, Alibazoglu H, Ali A, Fordham E, LaMonica G. Normal thymic uptake of FDG on PET imaging. Clin Nucl Med 1996; 21(10): 772-775.
28. Brink I, Reinhardt MJ, Hoegerle S, Altehoefer C, Moser E, Nitzsche EU. Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med 2001; 42(4): 591-595.
29. Nakahara T, Fujii H, Ide M, et al. FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT. Br J Radiol 2001; 74(885): 821-824.